Solid Biosciences (SLDB)

JMP Securities restated their market outperform rating on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a report released on Friday,Benzinga reports. They currently have a $15.00 price o… [+3672 chars]...

Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for shares of Solid Biosciences in a note issued to investors on Monday… [+3728 chars]...

HC Wainwright restated their buy rating on shares of Solid Biosciences (NASDAQ:SLDB – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. HC Wainwright currently has a $2… [+4055 chars]...

CHARLESTOWN, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the Company), a life sciences company developing precision genetic medicines for neuromuscular and cardiac… [+1866 chars]...

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have been given a consensus rating of “Buy” by the thirteen brokerages that are covering the stock, Marketbeat reports. Ten equities r… [+3990 chars]...

Two Sigma Investments LP lessened its holdings in Solid Biosciences Inc. (NASDAQ:SLDB – Free Report) by 32.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 136,145 shares of the… [+4431 chars]...